Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999–2009
Name
Berndt_Quality adjustment.pdf
Size
506.73 KB
Format
Adobe PDF
Checksum (MD5)
53f7689b2f87e173612d9ce04495873a
Author(s)
Eggleston, Karen N
Shah, Nilay D
Smith, Steven A
Berndt, Ernst R.
Newhouse, Joseph P.
Date Issued
May 2011
Journal
American Economic Review
Publisher
American Economic Association
Citation
Eggleston, Karen N, Nilay D Shah, Steven A Smith, Ernst R Berndt, and Joseph P Newhouse. “Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999–2009.” American Economic Review 101, no. 3 (May 2011): 206–211.
Version
Final published version
Abstract
Although US health care expenditures reached 17.6 percent of GDP in 2009, quality measurement in this important service sector remains limited. Studying quality changes associated with 11 years of health care for patients with diabetes, we find that the value of reduced mortality and avoided treatment spending, net of the increase in annual spending, was $9,094 for the average patient. These results suggest that the unit cost of diabetes treatment, adjusting for the value of health outcomes, has been roughly constant. Since input prices have not been declining, our results are consistent with productivity improvement in health care.
MIT Department
Sloan School of Management
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1257/aer.101.3.206
